InvestorsHub Logo
Followers 829
Posts 119615
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Friday, 02/25/2022 11:39:50 AM

Friday, February 25, 2022 11:39:50 AM

Post# of 195
MYOV—CHMP approves Orgovyx for HSPC:

https://www.globenewswire.com/news-release/2022/02/25/2392377/0/en/Myovant-Sciences-Receives-Positive-CHMP-Opinion-for-ORGOVYX-relugolix-for-the-Treatment-of-Advanced-Prostate-Cancer.html

MYOV is still seeking a partner for the European rights to Orgovyx. The PR says MYOV expects to have a deal in the next two months or so.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”